1/1
Drugs12_011707.jpg
Former, Rep. Billy Tauzin, R-La., CEO of PhRMAArlen, goes over some paper work while Arlen Specter, R-PA., and Patrick Leahy,D-VT., question Jon   Leibowitz, commissioner at the Federal Trade Commission during a full committee hearing on "Paying Off Generics to Prevent Competition with Brand Name Drugs.

Former, Rep. Billy Tauzin, R-La., CEO of PhRMAArlen, goes over some paper work while Arlen Specter, R-PA., and Patrick Leahy,D-VT., question Jon Leibowitz, commissioner at the Federal Trade Commission during a full committee hearing on "Paying Off Generics to Prevent Competition with Brand Name Drugs.

Copyright CQ Roll Call